Bortezomib, a drug that already is an approved therapy for some cancers, also might be an effective secondary treatment for a rare tumor of the gastrointestinal tract, say researchers.
Bortezomib, a drug that already is an approved therapy for some cancers, also might be an effective secondary treatment for a rare tumor of the gastrointestinal tract, say researchers.